(NYSE: RVTY) Revvity's forecast annual revenue growth rate of 4.79% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 5.95%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.03%.
Revvity's revenue in 2024 is $2,750,571,000.On average, 5 Wall Street analysts forecast RVTY's revenue for 2024 to be $347,803,399,278, with the lowest RVTY revenue forecast at $346,415,912,329, and the highest RVTY revenue forecast at $348,984,097,307. On average, 6 Wall Street analysts forecast RVTY's revenue for 2025 to be $370,787,110,714, with the lowest RVTY revenue forecast at $367,501,217,475, and the highest RVTY revenue forecast at $375,355,243,494.
In 2026, RVTY is forecast to generate $403,302,630,197 in revenue, with the lowest revenue forecast at $403,208,747,533 and the highest revenue forecast at $403,396,512,861.